Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for EBOSY and 80,000+ other tickers.
See exactly how EBOSY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for EBOSY and 80,000+ other tickers.
EBOS Group Limited, established in 1922 and headquartered in Docklands, Australia, operates as a prominent marketer, wholesaler, and distributor of a broad spectrum of healthcare, medical, pharmaceutical, and animal care products. Its operations span Australia, New Zealand, and Southeast Asia, structured primarily around its Healthcare and Animal Care divisions. The Healthcare segment offers a comprehensive suite of services and products. These include intricate healthcare logistics, medication management systems, and specialized pharmacy management software. The software solutions cover…
EBOS Group Limited (EBOSY) Q4 2026 Earnings Call Transcript
EBOS Group Limited (EBOSY) Analyst/Investor Day Transcript
EBOS Group Limited (EBOSF) Q2 2026 Earnings Call Transcript